ReviewDrugs2014
Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastases.
Matt Shirley et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it